Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yoshiki Nagai, Naoto Yokogawa, Kota Shimada & Shoji Sugii. (2019) Comparison of the clinical characteristics and severity of community-acquired pneumonia between patients with rheumatoid arthritis treated with tocilizumab and those treated with TNF inhibitor. Modern Rheumatology 29:5, pages 782-787.
Read now
Read now
Atsushi Ogata, Yasuhiro Kato, Shinji Higa & Kazuyuki Yoshizaki. (2019) IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review. Modern Rheumatology 29:2, pages 258-267.
Read now
Read now
Articles from other publishers (4)
Alfredo Madrid-García, Beatriz Merino-Barbancho, Alejandro Rodríguez-González, Benjamín Fernández-Gutiérrez, Luis Rodríguez-Rodríguez & Ernestina Menasalvas-Ruiz. (2023) Understanding the role and adoption of artificial intelligence techniques in rheumatology research: An in-depth review of the literature. Seminars in Arthritis and Rheumatism 61, pages 152213.
Crossref
Crossref
Mark Berman, Ronen Ben-Ami, Shlomo Berliner, Marina Anouk, Ilana Kaufman, Adi Broyde, Sara Borok & Ori Elkayam. (2021) The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature. Life 11:3, pages 258.
Crossref
Crossref
Sandra Rodríguez, Andrés Muñoz, Rosa-Helena Bustos & Diego Jaimes. (2020) Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview. Biomedicines 8:9, pages 303.
Crossref
Crossref
David Armstrong, Alex Dregan, Mark Ashworth, Patrick White, Chris McGee & Simon de Lusignan. (2020) Influence of prior antibiotic use on risk of rheumatoid arthritis: case control study in general practice. Rheumatology 59:6, pages 1281-1287.
Crossref
Crossref